Pantoprazole and Blast cell count increased - a phase IV clinical study of FDA data

Summary:

Blast cell count increased is reported as a side effect among people who take Pantoprazole (pantoprazole sodium), especially for people who are male, 30-39 old, also take Clozaril, and have Primary myelofibrosis.

The phase IV clinical study analyzes which people have Blast cell count increased when taking Pantoprazole. It is created by eHealthMe based on reports of 281,696 people who have side effects when taking Pantoprazole from the FDA, and is updated regularly.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,165 Pantoprazole users. Check the latest studies of Pantoprazole.

What is Blast cell count increased?

Blast cell count increased is found to be associated with 114 drugs and 179 conditions by eHealthMe. Check the latest studies of Blast cell count increased.

On Jul, 07, 2026

281,696 people reported to have side effects when taking Pantoprazole.
Among them, 21 people (0.01%) have Blast cell count increased.

Could Pantoprazole cause Blast cell count increased?

Among these 21 people:

What is the gender of people who have Blast cell count increased when taking Pantoprazole? *

female: 21.43 %
male: 78.57 %

What is the age of people who have Blast cell count increased when taking Pantoprazole? *

What are other drugs people take besides Pantoprazole? *

What are other side effects people have besides Blast cell count increased? *

C-Reactive Protein Increased: 13 people, 61.90%
Blood Sodium Decreased: 12 people, 57.14%
Troponin Increased: 10 people, 47.62%
Gamma-Glutamyltransferase Increased: 9 people, 42.86%
Haemoglobin Decreased: 8 people, 38.10%
Blood Osmolarity Decreased: 8 people, 38.10%
Myelocyte Count Increased (a young white blood cell found in the bone marrow increased): 8 people, 38.10%
Blood Bicarbonate Decreased: 8 people, 38.10%
Protein Total Increased: 8 people, 38.10%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 8 people, 38.10%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 28.57%
Primary Myelofibrosis (primary disorder of the bone marrow): 6 people, 28.57%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 19.05%
Type 2 Diabetes: 3 people, 14.29%
Joint Pain: 2 people, 9.52%
Essential Thrombocythaemia (chronic blood cancer): 2 people, 9.52%
Depression: 2 people, 9.52%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 9.52%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 9.52%
Ovarian Cancer (cancer of ovary): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and have Blast cell count increased?

- Check whether Blast cell count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pantoprazole:

Pantoprazole (285,165 reports)

Browse all side effects of Pantoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blast cell count increased:

Blast cell count increased (114 drugs)

Browse all the conditions that are associated with Blast cell count increased:

Blast cell count increased (179 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium (the active ingredients of Pantoprazole) and Pantoprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.